The Pharmaceutical Market: Czech Republic
OVERVIEW OF THE PHARMACEUTICAL
MARKET IN CZECH REPUBLIC
The recent measures proposed by the Czech
Republic\'s Ministry of Health will, in all likelihood, negatively
affect the Czech pharmaceutical market. The introduction of
reimbursement ceilings, blind bidding auctions and preferential
prescribing will squeeze drugmakers\' margins and shift some of the
burden of healthcare spending onto the private sector. The outcome of
similar measures in Hungary and Poland strongly supports our view
that the business environment for drugmakers will worsen if these
proposals are adopted. It is patients who, ultimately, will suffer.
Headline Expenditure Projections
Pharmaceuticals: CZK80.71bn (US$4.56bn) in
2011 to CZK79.76bn (US$4.2bn) in 2012; -1.2% in local currency terms
and -7.1% in US dollar terms.
Healthcare: CZK298.49bn (US$16.88bn) in
2011 to CZK297.87bn (US$15.831bn) in 2012; +0.4% in local currency
terms and -8.4% in US dollar terms.
Medical Devices: CZK26.51n (US$1.50bn) in
2011 to CZK26.91bn (US$1.43bn) in 2012; +1.5% in local currency terms
and -4.6% in US dollar terms. Forecast moderat ely down due to
macroeconomic factors.
To
Browse a Full Report with TOC @
http://www.researchmoz.us/the-pharmaceutical-market-czech-republic-report.html
Risk/Reward
Rating
The
Czech Republic retains its leading position in the CEE RRRs in Q113,
after displacing Poland in our Q412 assessment. Despite leading in
our regional RRR table, the outlook for growth for the Czech
pharmaceutical market is not particularly robust, as a result of
pricing pressure, impeded market entry and increasing generic
substitution. An increase in VAT and a stringent reference pricing
system have affected sales and hit manufacturers\' margins
respectively.
Competitive
Landscape
The
competitive landscape section provides comparative company analyses
and rankings by US$ sales and % share of total sales - for the total
pharmaceutical sector, as well as the OTC, generics, and distribution
sub-sectors
Table
of Contents
Hospital
Sector 28
Research
& Development Sector 29
Clinical
Trials 30
Medical
Devices 31
Industry
Forecast Scenario 33
Overall
Market Forecast 33
Table:
Czech Pharmaceutical Sales, Historical Data And Forecasts 34
Key
Growth Factors - Industry 35
Table:
Czech Healthcare Expenditure Trends, Historical Data And Forecasts 36
Table:
Czech Government Healthcare Expenditure Trends, Historical Data And
Forecasts 37
Table:
Czech Private Healthcare Expenditure Trends, Historical Data And
Forecasts 37
Key
Growth Factors - Macroeconomic 38
Prescription
Drug Market Forecast 42
Table:
Czech Prescription Drug Market Indicators, Historical Data and
Forecasts 43
Patented
Drug Market Forecast 44
Table:
Czech Patented Drug Market Indicators, Historical Data and Forecasts
45
Generic
Drug Market Forecast 46
Table:
Czech Generics Drug Market Indicators, Historical Data and Forecasts
46
For More Information Kindly Contact:
ResearchMoz
Mr.
Nachiket Ghumare,
Tel:
866-997-4948
(Us-Canada
Toll Free)
Tel:
+1-518-621-2074
Website:
http://www.researchmoz.us
Comments
Post a Comment